Sofia Lysenko’s parents moved to the United States from the Ukraine when she was 3 years old. Today, at 17, some of the biggest American pharmaceutical companies want to team up with this teenage science prodigy because she has created an artificial macromolecule robot that can deliver drugs directly to the brain cells of patients with Alzheimer’s and Parkinson’s. Iryna Matviichuk met with Sofia to learn more. Anna Rice narrates her report.
Joolam skype chat
news
- VOA Indonesian: Indonesians in Los Angeles evacuate amid devastating fires 01/14/2025
- US agencies warn of potential New Orleans copycat attack 01/14/2025
- Elon Musk says third patient got Neuralink brain implant 01/13/2025
- Biden defends foreign policy record despite ongoing crises 01/13/2025
- Baltimore prosecutors back Adnan Syed’s request to have his sentence reduced to time served 01/13/2025
subscribe via email
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy